查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1953716

全球尼古丁口香糖市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Nicotine Gum Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 113 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計尼古丁口香糖市場將從 2025 年的 22 億美元成長到 2034 年的 37.7 億美元，2026 年至 2034 年的複合年成長率為 6.18%。

隨著越來越多的人尋求有效的戒菸方法並控制尼古丁癮，尼古丁口香糖市場正經歷顯著成長。尼古丁口香糖是一種尼古丁替代療法（NRT），它能幫助吸菸者減少對尼古丁的依賴，同時減輕戒斷症狀和菸癮。隨著公共衛生措施和宣傳宣傳活動不斷推動戒菸，預計對尼古丁口香糖的需求將持續成長。尤其是在各國政府和衛生組織持續推行旨在降低吸菸率和倡導健康生活方式的政策之際，這一趨勢顯得尤為重要。

此外，人們對健康和保健日益成長的興趣也影響著尼古丁口香糖市場。隨著消費者健康意識的增強，對能夠幫助他們戒菸並促進整體健康的產品需求也日益成長。為了順應這一趨勢，製造商正在開發各種口味和配方的尼古丁口香糖，以滿足不同消費者的偏好。隨著越來越多的人尋求更具吸引力且有效的戒菸方法，這種多元化預計將推動市場成長。

此外，研發領域的進步正在改變尼古丁口香糖市場的格局。市場創新主要源自於新配方的研發，這些新配方能夠提高尼古丁口香糖的功效並改善使用者體驗。此外，行動應用程式和線上支援計畫等數位健康技術的整合，為吸菸者提供了更多資源和工具，以幫助他們戒菸。因此，在公共衛生舉措、消費者偏好變化以及戒菸解決方案進步的推動下，尼古丁口香糖市場預計將迎來顯著成長。

目錄

第1章 引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 繪製滲透率和成長前景圖
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制
    • 市場機遇
    • 市場問題
  • 波特五力分析
  • PESTLE分析

4. 全球尼古丁口香糖市集（按類型分類）

  • 市場分析、洞察與預測
  • 2mg
  • 4mg

5. 全球尼古丁口香糖市集依通路分類

  • 市場分析、洞察與預測
  • 超級市場和大賣場
  • 便利商店
  • 藥局
  • 線上

6. 全球尼古丁口香糖市集（按地區分類）

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第7章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商格局（基於現有資訊）
  • 策略規劃

第8章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Johnson & Johnson
    • Novartis AG
    • ITC Limited
    • Cipla Health Limited
    • Perrigo Company Plc
    • Teva Canada
    • Philip Morris
    • British American Tobacco PLC
    • Revolymer
    • Fertin Pharma
簡介目錄
Product Code: VMR112112017

The Nicotine Gum Market size is expected to reach USD 3.77 Billion in 2034 from USD 2.20 Billion (2025) growing at a CAGR of 6.18% during 2026-2034.

The nicotine gum market is experiencing significant growth as more individuals seek effective solutions to quit smoking and manage nicotine cravings. Nicotine gum, a form of nicotine replacement therapy (NRT), provides smokers with a way to reduce withdrawal symptoms and cravings while gradually decreasing their dependence on nicotine. As public health initiatives and awareness campaigns promote smoking cessation, the demand for nicotine gum is expected to rise. This trend is particularly relevant as governments and health organizations continue to implement policies aimed at reducing smoking rates and promoting healthier lifestyles.

Moreover, the increasing focus on health and wellness is influencing the nicotine gum market. As consumers become more health-conscious, there is a growing demand for products that support smoking cessation and promote overall well-being. Manufacturers are responding to this trend by developing nicotine gum with various flavors and formulations that cater to different consumer preferences. This diversification is expected to drive market growth as more individuals seek appealing and effective options for quitting smoking.

Additionally, advancements in research and development are transforming the nicotine gum landscape. The development of new formulations that enhance the effectiveness of nicotine gum and improve user experience is driving innovation in the market. Furthermore, the integration of digital health technologies, such as mobile apps and online support programs, is providing smokers with additional resources and tools to aid in their cessation efforts. The nicotine gum market is thus positioned for significant growth, driven by public health initiatives, changing consumer preferences, and advancements in smoking cessation solutions.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

  • 2mg
  • 4mg

By Distribution Channel

  • Supermarkets/Hypermarkets
  • Convenience Stores
  • Pharmacies
  • Online

COMPANIES PROFILED

  • Johnson Johnson, Novartis AG, ITC Limited, Cipla Health Limited, Perrigo Company Plc, Teva Canada, Philip Morris, British American Tobacco PLC, Revolymer, Fertin Pharma

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL NICOTINE GUM MARKET: BY TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Type
  • 4.2. 2mg Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. 4mg Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL NICOTINE GUM MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Distribution Channel
  • 5.2. Supermarkets/Hypermarkets Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Convenience Stores Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Online Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL NICOTINE GUM MARKET: BY REGION 2022-2034(USD MN)

  • 6.1. Regional Outlook
  • 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.2.1 By Type
    • 6.2.2 By Distribution Channel
    • 6.2.3 United States
    • 6.2.4 Canada
    • 6.2.5 Mexico
  • 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.3.1 By Type
    • 6.3.2 By Distribution Channel
    • 6.3.3 United Kingdom
    • 6.3.4 France
    • 6.3.5 Germany
    • 6.3.6 Italy
    • 6.3.7 Russia
    • 6.3.8 Rest Of Europe
  • 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.4.1 By Type
    • 6.4.2 By Distribution Channel
    • 6.4.3 India
    • 6.4.4 Japan
    • 6.4.5 South Korea
    • 6.4.6 Australia
    • 6.4.7 South East Asia
    • 6.4.8 Rest Of Asia Pacific
  • 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.5.1 By Type
    • 6.5.2 By Distribution Channel
    • 6.5.3 Brazil
    • 6.5.4 Argentina
    • 6.5.5 Peru
    • 6.5.6 Chile
    • 6.5.7 South East Asia
    • 6.5.8 Rest of Latin America
  • 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.6.1 By Type
    • 6.6.2 By Distribution Channel
    • 6.6.3 Saudi Arabia
    • 6.6.4 UAE
    • 6.6.5 Israel
    • 6.6.6 South Africa
    • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

  • 7.1. Recent Developments
  • 7.2. Company Categorization
  • 7.3. Supply Chain & Channel Partners (based on availability)
  • 7.4. Market Share & Positioning Analysis (based on availability)
  • 7.5. Vendor Landscape (based on availability)
  • 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL NICOTINE GUM INDUSTRY

  • 8.1. Top Companies Market Share Analysis
  • 8.2. Company Profiles
    • 8.2.1 Johnson & Johnson
    • 8.2.2 Novartis AG
    • 8.2.3 ITC Limited
    • 8.2.4 Cipla Health Limited
    • 8.2.5 Perrigo Company Plc
    • 8.2.6 Teva Canada
    • 8.2.7 Philip Morris
    • 8.2.8 British American Tobacco PLC
    • 8.2.9 Revolymer
    • 8.2.10 Fertin Pharma